Cell & Gene Therapy Manufacturing

Pharama | November 15, 2016

Along with forensic evidence in criminal cases, this process can be applied to many situations, said study lead investigator Pieter Dorrestein, a professor in UCSD's School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences....

Allergan | December 22, 2016

US-based drugmaker Allergan has signed an agreement to acquire Acelity’s regenerative medicine unit LifeCell in a deal valued at $2.9bn.The acquisition will combine LifeCell's business, including its portfolio of dermal matrix products with Allergan's portfolio of medical aesthetics, breast implants and tissue expanders....

PharmiWeb Solutions | February 10, 2017

Greiner Bio-One North America, Inc. has added a new and innovative product to the already robust portfolio for cell culture that is specifically used for mass cell culture. CELLdisc™ is a new multilayer device covering a range of cell culture surfaces from 1,000 cm2 up to 1 square meter. The innovative ergonomic design of CELLdisc™ provides a versatile system for the propagation of adherent mammalian cells from research scale to industrial batches....

Denovo Biopharma | February 16, 2017

Denovo Biopharma LLC, a leading company in precision medicine announces the plan to initiate a biomarker driven global phase 3 clinical trial for its lead drug DB102 as a first line therapy for diffuse large B-cell lymphoma (DLBCL) patients this year....